Edmund Dunn
Principal Accounting Officer · Monte Rosa Therapeutics, Inc.
- 2026
- Mar 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Edmund Dunn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Filip Janku - $1.38M in GLUE purchases and sales in the last 12 months
- Markus Warmuth - $951K in GLUE purchases and sales in the last 12 months
- Sharon Townson - $424K in GLUE purchases and sales in the last 12 months
- Anthony M. Manning - $411K in GLUE purchases and sales in the last 12 months
- Jennifer Champoux - $311K in GLUE purchases and sales in the last 12 months
- Philip Nickson - $151K in GLUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Edmund Dunn?
Edmund Dunn is a corporate insider, tracked as Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Edmund Dunn last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 3 filings going back to 2026.
Has Edmund Dunn been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($483K) across all tracked filings.
